These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 21984893)
21. Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways. Shi W; Fang Y; Jiang Y; Jiang S; Li Y; Li W; Xu M; Aschner M; Liu G Bioengineered; 2021 Dec; 12(1):4475-4488. PubMed ID: 34304701 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway. Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479 [TBL] [Abstract][Full Text] [Related]
23. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. Runyan CE; Schnaper HW; Poncelet AC J Biol Chem; 2004 Jan; 279(4):2632-9. PubMed ID: 14610066 [TBL] [Abstract][Full Text] [Related]
24. Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148. Tsoyi K; Chu SG; Patino-Jaramillo NG; Wilder J; Villalba J; Doyle-Eisele M; McDonald J; Liu X; El-Chemaly S; Perrella MA; Rosas IO Am J Respir Cell Mol Biol; 2018 Feb; 58(2):208-215. PubMed ID: 28886261 [TBL] [Abstract][Full Text] [Related]
26. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion. Selige J; Hatzelmann A; Dunkern T J Cell Physiol; 2011 Aug; 226(8):1970-80. PubMed ID: 21520048 [TBL] [Abstract][Full Text] [Related]
27. The fibrotic role of phosphatidylinositol-3-kinase/Akt pathway in injured skeletal muscle after acute contusion. Li HY; Zhang QG; Chen JW; Chen SQ; Chen SY Int J Sports Med; 2013 Sep; 34(9):789-94. PubMed ID: 23444088 [TBL] [Abstract][Full Text] [Related]
28. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
29. Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation. Winbanks CE; Grimwood L; Gasser A; Darby IA; Hewitson TD; Becker GJ Int J Biochem Cell Biol; 2007; 39(1):206-19. PubMed ID: 16973406 [TBL] [Abstract][Full Text] [Related]
30. Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms. Blanco B; Herrero-Sánchez MC; Rodríguez-Serrano C; Sánchez-Barba M; Del Cañizo MC Immunol Res; 2015 Jun; 62(2):175-88. PubMed ID: 25869396 [TBL] [Abstract][Full Text] [Related]
31. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477 [TBL] [Abstract][Full Text] [Related]
33. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation. Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687 [TBL] [Abstract][Full Text] [Related]
34. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Guo W; Shan B; Klingsberg RC; Qin X; Lasky JA Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L864-70. PubMed ID: 19700647 [TBL] [Abstract][Full Text] [Related]
36. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. Zhang B; Liu P; Zhou Y; Chen Z; He Y; Mo M; Dai G; Xia W; Du Y; Liu Y; Chen X Life Sci; 2019 Apr; 223():29-37. PubMed ID: 30862567 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. Dunkern TR; Feurstein D; Rossi GA; Sabatini F; Hatzelmann A Eur J Pharmacol; 2007 Oct; 572(1):12-22. PubMed ID: 17659276 [TBL] [Abstract][Full Text] [Related]
38. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy. Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568 [TBL] [Abstract][Full Text] [Related]
39. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts. Peng H; Carretero OA; Peterson EL; Rhaleb NE Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264 [TBL] [Abstract][Full Text] [Related]
40. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]